Article
Lakeland, Fla. — Molecular staging of melanoma can identify patients with missed micrometastatic disease, offering them the chance to receive more aggressive treatment, thus offering them the best chance of survival.
Daily Derm Times: March 25, 2025
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Quoin Files US Patent Applications for Rare Disease Treatments
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Understanding Neomycin-Induced Contact Allergy
Nanoneedles Enhance CRISPR Base Editing for RDEB Treatment, Achieving 96.5% Correction Efficiency